Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05502328 · ClinicalTrials.gov registry record · NA
Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,427
- Enrollment target
NCT05502328: Completed NA study, sponsored by Radicle Science.
NCT05502328 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 1,427 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05502328, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,427 participants
- Enrollment target
Study Summary
A randomized, blinded, placebo-controlled study of cannabinoid formulations and their effects on energy levels, focus, appetite and other health outcomes
Primary Outcome
Change in mean energy score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 7a (scale 1-5; where lower score is less fatigue)
Interventions
- DIETARY_SUPPLEMENT Energy Study Product Usage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,427 participants |
| Start Date | 2022-08-17 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
What the finished NCT05502328 record still lists
NCT05502328 is an interventional study that assigns participants to a tested intervention. Its 1,427 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Energy Study Product Usage is the first listed.
NCT05502328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05502328 about?
NCT05502328 is a clinical study titled "Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes". A randomized, blinded, placebo-controlled study of cannabinoid formulations and their effects on energy levels, focus, appetite and other health outcomes
What is the current status of trial NCT05502328?
This trial is currently completed. It is a NA study. The enrollment target is 1,427 participants. The study started on 2022-08-17. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05502328?
The interventions under investigation include: Energy Study Product Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05502328?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05502328's enrollment target sits among peer trials
1,427 70th of 2000 higher than 1,931 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI